Literature DB >> 34448248

CARD14-associated papulosquamous eruption (CAPE) in pediatric patients: Three additional cases and review of the literature.

Cindy P Frare1, Alli J Blumstein2, Amy S Paller2, Lia Pieretti3, Keith A Choate4, Anne M Bowcock5, Margarita Larralde1,6.   

Abstract

CARD14-associated papulosquamous eruption (CAPE) is a proposed term that encompasses features ranging from psoriasis to pityriasis rubra pilaris (PRP) in association with CARD14 mutations. The early onset of the disease, prominent facial involvement, family history of an autosomal dominant trait, and poor response to conventional treatment are characteristics of CAPE that distinguish it from classical psoriasis and PRP. We describe the clinical features, family history, and response to therapy in three unrelated children with CAPE and compare these characteristics with those of previously described pediatric patients. Testing for CARD14 mutations in children with early onset of features of psoriasis or pityriasis rubra pilaris and resistance to conventional therapy should be considered.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  zzm321990CARD14zzm321990; child; pityriasis rubra pilaris; psoriasis; ustekinumab

Mesh:

Substances:

Year:  2021        PMID: 34448248      PMCID: PMC8578307          DOI: 10.1111/pde.14779

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.997


  20 in total

1.  Ustekinumab as therapy for psoriasis in a 2-year-old girl.

Authors:  M S Min; A Shroff; S Rose; M Lebwohl; E Guttman-Yassky
Journal:  J Eur Acad Dermatol Venereol       Date:  2015-09-16       Impact factor: 6.166

2.  Rapid response of pityriasis rubra pilaris with psoriasis overlap to secukinumab.

Authors:  D Cole; T Mohammad; H Lim
Journal:  Br J Dermatol       Date:  2019-08-27       Impact factor: 9.302

3.  Clinical response to ustekinumab in familial pityriasis rubra pilaris caused by a novel mutation in CARD14.

Authors:  O Eytan; O Sarig; E Sprecher; M A M van Steensel
Journal:  Br J Dermatol       Date:  2014-08-06       Impact factor: 9.302

4.  Familial pityriasis rubra pilaris is caused by mutations in CARD14.

Authors:  Dana Fuchs-Telem; Ofer Sarig; Maurice A M van Steensel; Ofer Isakov; Shirli Israeli; Janna Nousbeck; Katharina Richard; Veronique Winnepenninckx; Marigje Vernooij; Noam Shomron; Jouni Uitto; Philip Fleckman; Gabriele Richard; Eli Sprecher
Journal:  Am J Hum Genet       Date:  2012-06-14       Impact factor: 11.025

5.  Pityriasis Rubra Pilaris Type V as an Autoinflammatory Disease by CARD14 Mutations.

Authors:  Takuya Takeichi; Kazumitsu Sugiura; Toshifumi Nomura; Taiko Sakamoto; Yasushi Ogawa; Naoki Oiso; Yuko Futei; Aki Fujisaki; Akiko Koizumi; Yumi Aoyama; Kimiko Nakajima; Yutaka Hatano; Kei Hayashi; Akemi Ishida-Yamamoto; Sakuhei Fujiwara; Shigetoshi Sano; Keiji Iwatsuki; Akira Kawada; Yasushi Suga; Hiroshi Shimizu; John A McGrath; Masashi Akiyama
Journal:  JAMA Dermatol       Date:  2017-01-01       Impact factor: 10.282

6.  Beneficial effect of ustekinumab in familial pityriasis rubra pilaris with a new missense mutation in CARD14.

Authors:  S M Lwin; C-K Hsu; L Liu; H-Y Huang; N J Levell; J A McGrath
Journal:  Br J Dermatol       Date:  2017-10-01       Impact factor: 9.302

7.  Interleukin 23-Helper T Cell 17 Axis as a Treatment Target for Pityriasis Rubra Pilaris.

Authors:  Laurence Feldmeyer; Alessio Mylonas; Olivier Demaria; Anna Mennella; Nikhil Yawalkar; Emmanuel Laffitte; Daniel Hohl; Michel Gilliet; Curdin Conrad
Journal:  JAMA Dermatol       Date:  2017-04-01       Impact factor: 10.282

8.  A patient with CARD14-associated papulosquamous eruptions showing atopic dermatitis-like features.

Authors:  T Takeichi; S Terawaki; Y Kubota; Y Ito; K Tanahashi; Y Muro; M Akiyama
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-07-22       Impact factor: 6.166

9.  Two cases of CARD14-associated papulosquamous eruption from India.

Authors:  Minu Jose Chiramel; Dharshini Sathishkumar; Eunice Sindhuvi Edison; Renu George
Journal:  Pediatr Dermatol       Date:  2020-04-23       Impact factor: 1.588

10.  Successful Treatment of Pityriasis Rubra Pilaris with Ixekizumab.

Authors:  Kathrin Hanfstingl; Agnes Pekar-Lukacs; Reinhard Motz; Emmanuella Guenova; Wolfram Hoetzenecker
Journal:  Case Rep Dermatol       Date:  2018-05-02
View more
  1 in total

Review 1.  The Clinical Chameleon of Autoinflammatory Diseases in Children.

Authors:  Eugenio Sangiorgi; Donato Rigante
Journal:  Cells       Date:  2022-07-18       Impact factor: 7.666

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.